Key Takeaways
- Scientific Evidence: Major studies from Harvard, Johns Hopkins, and Mount Sinai show links between prenatal acetaminophen use and increased risks of autism and ADHD.
- Trump’s Leadership: The President is prioritizing families by spotlighting credible research and launching new initiatives to address skyrocketing autism diagnoses.
- Media Distraction: Instead of covering the science, the mainstream press rushed to smear Trump, ignoring the very real health concerns for America’s children.
President Donald J. Trump is once again leading where others have failed. Yesterday, he joined administration officials to unveil groundbreaking initiatives aimed at understanding and addressing the root causes of autism — a condition that has seen diagnoses skyrocket in recent decades.
Predictably, the corporate media went into full meltdown mode, smearing Trump instead of grappling with the facts. But the science is on the President’s side. Mounting evidence shows a troubling link between prenatal acetaminophen use and higher risks of autism and ADHD in children.
Large-scale studies from Harvard, Johns Hopkins, and Mount Sinai have all reported associations between Tylenol use during pregnancy and later diagnoses of autism spectrum disorder and attention-deficit/hyperactivity disorder. Harvard’s Dr. Andrea Baccarelli explained it bluntly: “We found evidence of an association between exposure to acetaminophen during pregnancy and increased incidence of neurodevelopmental disorders in children.”
This isn’t fringe science — it’s coming from the nation’s top medical institutions. In fact, back in 2021, an international consensus statement urged “precautionary action,” recommending pregnant women minimize exposure by using the lowest possible dose for the shortest duration.
For years, Big Pharma and its allies have downplayed these concerns. But Trump is making it clear that parents — and future generations — deserve the truth. By spotlighting credible research and demanding accountability, the administration is putting families first, not pharmaceutical profits.
The choice is simple: ignore the evidence and protect industry interests, or follow Trump’s lead and fight for America’s children.